Clinical Trial Detail

NCT ID NCT02780804
Title Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

central nervous system cancer

lymphoma

Advanced Solid Tumor

Therapies

Entinostat

Age Groups: adult child

No variant requirements are available.